Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changes: Estradiol Variability and Affective Symptoms in Perimenopause
NCT03003949Phase 4Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2017
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of estradiol topical in perimenopause, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: State-Trait Anxiety Inventory at 24 weeks. Started Jan 2017; status: terminated.
02
Drugs
estradiol topical
03
Conditions
perimenopause
Beyond the preview
Go deeper on NCT03003949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03003949.